News

Here is Why NACCO Industries (NC) Gained This Week
The share price of NACCO Industries, Inc. (NYSE:NC) surged by 4.57% between May 14 and May 21, 2025, putting it among the ...
3 Key Questions For Equity Investors To Consider
Volatility is likely to remain elevated amid ongoing uncertainty about U.S. trade policy and bilateral tariff negotiations.
Investors, Be Careful When Buying New ETFs
From an ETF provider’s perspective, creating new ETFs with different risk/reward profiles solves two problems. It’s a new ...
NextEra Energy Inc. Jr. Sub. Deb. Series U
In the past Mr. Hachigian was Chairman at JELD-WEN Holding, Inc. and Non-Executive Chairman of JELD-WEN, Inc. (a subsidiary of JELD-WEN Holding, Inc.), Principal at Skykarr Capital LLC, Chairman & ...
A Closer Look At Vail Resorts, Inc.'s (NYSE:MTN) Impressive ROE
While some investors are already well versed in financial metrics (hat tip), this article is for those who would ...
Rackspace: Shifting To Higher-Margin Cloud, Amid Risks (Rating Downgrade)
After its sustained decline, Rackspace is now a penny stock, not far from the one-dollar-per-share threshold. Read why it is ...
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. in connection with its $13.5 Million Initial Public Offering
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / On May 12, 2025, Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) ("Apimeds" or the "Company"), a clinical stage biopharmaceutical company that is in t ...